1-3 of 3
María José Ramirez
Close
Sort by
Journal Articles

Efficacy of Autologous Stem-Cell Transplantation in Patients with Relapsed or Refractory Aggressive B-Cell Lymphoma in the Rituximab Era. A Multicenter Geltamo Study.

Alba María Redondo, Alejandro Martín, Helena Pomares, María Jesús Vidal, María Jesús Pascual, Beatriz Quereda, Juan Manuel Sancho, Sr., MD, Joaquín Díaz-Mediavilla, Javier López, Eulogio Conde, MD, PhD, Isidro Jarque, MD, Natalia Alonso, María José Ramirez, María José Sayas, María José Requena, Antonio Salar, MD, José David González, MD, Eva González-Barca, MD, PhD, Reyes Arranz, Jesús F San Miguel, Dolores Caballero, MD
Journal: Blood
Blood (2012) 120 (21): 3142.
https://doi.org/10.1182/blood.V120.21.3142.3142
Published: 2012
Journal Articles

Prognostic Value of Interim PET/CT in Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL). Experience of the Spanish Geltamo Group

Mónica Coronado, Emilia Pardal, Rosa Couto, Fatima de la Cruz, Carlos Panizo, Carlos Grande, Reyes Arranz, MD, María José Ramirez, Roberto Hernández, Alejandro Martin, Dolores Caballero, MD
Journal: Blood
Blood (2012) 120 (21): 5076.
https://doi.org/10.1182/blood.V120.21.5076.5076
Published: 2012
Journal Articles

Bendamustine for Mantle Cell Lymphoma: Retrospective Analysis of the Spanish Experience

Ana García-Noblejas, MD, Belén Navarro Matilla, MD, Carolina Da Silva Rodriguez, Raquel De Oña Navarrete, MD, María José Ramirez Sánchez, MD, Concepción Nicolás, MD, Ricardo Pérez Fernández, Blanca Sanchez Gonzalez, MD, Eva Domingo-Domènech, MD, Jose Javier Sanchez Blanco, MD, Jimena Cannata-Ortiz, MD, Tomás José González-López, MD, Reyes Arranz Sáez, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4942.
https://doi.org/10.1182/blood.V118.21.4942.4942
Published: 2011